 |
Kara Palamountain is a Research Associate Professor at the Kellogg School
of Management where she serves as the Executive Director of the Global
Health Initiative. Kara's research focus is centered on medical diagnostics
for infectious diseases in the developing world. In 2003, she began working
with Dave Kelso on an initiative to develop and produce affordable HIV
diagnostics for the developing world which later obtained funding in 2006
from the Bill & Melinda Gates Foundation.
Prior to her work at Kellogg, Kara worked as a management consultant in Deloitte's
Healthcare practice for over six years where she specialized in Medicare Part
D strategy and implementation, pharmacy benefit management, and medical injectable
strategy.
Kara was awarded "2003 Ford Center Honorable Mention" for a white paper
on "Sustainable Foundations for HIV/AIDS Care in South Africa" which
was later published in the "Kellogg Anthology on Corporate Social Responsibility."
